home / stock / brtx / brtx news


BRTX News and Press, BioRestorative Therapies Inc From 06/17/25

Stock Information

Company Name: BioRestorative Therapies Inc
Stock Symbol: BRTX
Market: NASDAQ

Menu

BRTX BRTX Quote BRTX Short BRTX News BRTX Articles BRTX Message Board
Get BRTX Alerts

News, Short Squeeze, Breakout and More Instantly...

BRTX - BioRestorative Therapies announces share repurchase program; shares gain over 8%

2025-06-17 09:32:25 ET More on BioRestorative Therapies Seeking Alpha’s Quant Rating on BioRestorative Therapies Historical earnings data for BioRestorative Therapies Financial information for BioRestorative Therapies Read the full article on Seeking...

BRTX - BioRestorative Announces Share Repurchase Program

MELVILLE, N.Y., June 17, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage regenerative medicine innovator focused on stem cell-based therapies and produ...

BRTX - BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 - an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

– The International Society for Stem Cell Research (“ISSCR”) 2025 Annual Meeting is the world’s foremost gathering of stem cell and regenerative medicine leaders – – Updated data presented at ISSCR 2025 demonstrates >50% improvement in pain and fun...

BRTX - BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team

MELVILLE, N.Y., June 10, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage regenerative medicine innovator focused on stem cell-based therapies and produ...

BRTX - BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025

– New blinded safety and efficacy data from 30 patients in ongoing Phase 2 trial to be unveiled June 13, 2025 – – ISSCR 2025 is the premier global event for stem cell research, drawing nearly 4,000 leaders from academia, biotech, and pharma – – B...

BRTX - BioRestorative Therapies, Inc. (BRTX) Q1 2025 Earnings Call Transcript

2025-05-14 20:46:21 ET BioRestorative Therapies, Inc. (BRTX) Q1 2025 Earnings Call May 14, 2025 16:30 ET Company Participants Stephen Kilmer - Investor Relations Lance Alstodt - Chairman and Chief Executive Officer Francisco Silva - Vice President, Research and D...

BRTX - BioRestorative Therapies GAAP EPS of -$0.64 misses by $0.31

2025-05-14 16:16:53 ET More on BioRestorative Therapies BioRestorative Therapies, Inc. (BRTX) Q4 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on BioRestorative Therapies Historical earnings data for BioRestorative Therapies Financial info...

BRTX - BioRestorative Therapies Reports First Quarter 2025 Financial Results and Provides Business Update

MELVILLE, N.Y., May 14, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a regenerative medicine innovator focused on stem cell-based therapies and products, today repor...

BRTX - Expected US Company Earnings on Wednesday, May 14th, 2025

Aeva Technologies Inc. (AEVA) is expected to report $-0.59 for Q1 2025 Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil) (LND) is expected to report for Q3 2025 Omron Corporation ADR (OMRNY) is expected to report for Q4 2025 Sezzle Inc. (SEZL) is expected to report $0.3...

BRTX - BRTX - Historical Price Movements Surrounding Earnings

2025-05-13 18:48:10 ET BioRestorative Therapies, Inc. (BRTX) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 4.73%. The average open to low on the day of earnings was -3.72%. The average...

Previous 10 Next 10